Pac Premier
Giving Guide
You are here:  Home  >  Banking & Finance  >  Current Article

Amgen’s new drug could be a blockbuster

By   /   Friday, June 4th, 2021  /   Comments Off on Amgen’s new drug could be a blockbuster

    Print       Email
An Amgen researcher in lab that developed the new Lumakras cancer treatment (courtesy photo) In 2018, Amgen got its first green light to administer a new drug called sotorasib to people in clinical trials. Just three years later, that drug, now known as Lumakras, has been approved as a cancer treatment by the U.S. Food…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Limoneira, Calavo both report earnings growth as produce industry continues recovery

Read More →